Falkman , L., Sundin , A., Skogseid , B., Botling , J., Bernardo , Y., Wallin , G., Zhang , L., Welin , S., Lase , I., Mollazadegan , K., & Crona , J. (2024). Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. Upsala Journal of Medical Sciences, 129(S1), e10660. https://doi.org/10.48101/ujms.v129.10660